Drug Delivery News and Research

RSS

Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.

Biodegradable microneedle particles improve drug delivery through the skin

Your skin is remarkably good at keeping things out of your body. Typically, that's a positive. It becomes an issue when medicine needs to get in.

6 Nov 2026

Stony Brook-developed cancer drug advances to human clinical trials

A promising new cancer chemotherapeutic agent from a taxane class of natural compounds – anti-cancer agents designed to block cell division and trigger the programmed cell death to treat sold tumors – originally developed by researchers at Stony Brook University has entered human clinical trials.

6 Nov 2026

New review outlines role of extracellular vesicles in cancer and aging

A new review was published in Volume 13 of Oncoscience on September 30, 2026, titled "Extracellular vesicles in health, aging and disease."

6 Nov 2026

Review examines translational bottlenecks for plant-derived anti-inflammatory compounds

A review led by Professor Weidong Zhang at the School of Pharmacy, Naval Medical University, was published in Volume 2 of the journal Immunity & Inflammation on October 27, 2026. The article systematically examines the translational bottlenecks and potential solutions for plant-derived anti-inflammatory compounds.

5 Nov 2026

Targeted nanoimmunotherapy reduces atherosclerotic plaque burden in mice

This new article publication from Acta Pharmaceutica Sinica B discusses a targeted nanoimmunotherapy designed to restore macrophage clearance of dying cells, promote an anti-inflammatory phenotype, and reduce atherosclerotic plaque burden in mice.

4 Nov 2026

Traditional mulberry paper used to develop breathable health patch

Wearable health-monitoring devices are becoming increasingly important for personalized health care, but conventional patches often rely on substrates that restrict airflow, trap sweat, and cause skin discomfort during prolonged use.

4 Nov 2026

Natural body gas could help treat severe skin and wound infections

A gas naturally produced by our own bodies could one day help treat skin and wound infections, potentially offering a new approach alongside conventional antibiotics.

3 Nov 2026

1nhaler secures £2.2 million to continue late-stage development

The 1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.

3 Nov 2026

Novel transporter protein discovery opens new pathways for central nervous system therapies

Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system.

29 Oct 2026

Implantable drug-delivery device could help prevent recurrence of glioblastoma

Patients with glioblastoma, an aggressive type of brain tumor, usually undergo surgery to remove the tumor. However, it's difficult for surgeons to remove all of the cancer cells, and the tumor often recurs.

26 Oct 2026

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.

23 Oct 2026

Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer

A deeper understanding of mitochondrial function could create new opportunities for treating triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of breast cancer.

12 Oct 2026

A New Approach to Preventing Bladder Cancer Recurrence

Innovative techniques using electrical energy to treat bladder cancer may lower recurrence rates and minimize the need for radical surgical interventions.

8 Oct 2026

Innovative material uses visible light to disinfect chronic wounds

Chronic wounds place a burden on both patients and the healthcare system. Researchers at Empa are therefore working on an innovative material that releases active ingredients when exposed to visible light.

6 Oct 2026

Terumo announces global commercial launch of K-Pack Embrace™ active safety needle

Terumo Corporation today announced the global commercial launch of its K-Pack Embrace™ active safety needle.

From Terumo Corporation 6 Oct 2026

OnDosis and Adare Pharma Solutions announce strategic collaboration to advance OnDosis's lead U.S. ADHD program

OnDosis AB ("OnDosis"), a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform, and Adare Pharma Solutions ("Adare"), a technology-driven, integrated contract development and manufacturing organization (CDMO), today announced a strategic collaboration.

From OnDosis AB 1 Oct 2026

New mathematical model tracks how tumor environment impacts cancer therapies

Researchers from Mass General Brigham and the University of Cyprus have developed a sophisticated mathematical model to better understand how the tumor microenvironment affects the delivery and effectiveness of a new type of cancer therapy called an immunomodulatory antibody-drug conjugate (IM-ADC).

30 Sep 2026

Review highlights emerging treatments for glioblastoma multiforme

A new research perspective was published in Volume 13 of Oncoscience on September 17, 2026, titled "Emerging pharmacological agents for glioblastoma multiforme: An update on active clinical trials (2025–2026)."

25 Sep 2026

Forge Nano and Nanexa enter joint development agreement to advance manufacturing for ALD-coated PharmaShell® long-acting injectable medicines

Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II"), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell® drug delivery platform and its portfolio of proprietary and partnered programs.

From Forge Nano 23 Sep 2026

New slow-release drug delivery system provides weeks of pain-numbing anesthetic effects

Most local anesthetics used in medicine only last eight to 12 hours or a day tops. Now Boston Children's Hospital researchers have formulated a more effective slow-release injectable drug delivery system that achieved pain-numbing anesthetic effects lasting two to three weeks in rats compared to a commercial formulation lasting about four to eight hours.

23 Sep 2026

Drug Delivery News and Research

Further Reading

Biodegradable microneedle particles improve drug delivery through the skin

Stony Brook-developed cancer drug advances to human clinical trials

New review outlines role of extracellular vesicles in cancer and aging

Review examines translational bottlenecks for plant-derived anti-inflammatory compounds

Targeted nanoimmunotherapy reduces atherosclerotic plaque burden in mice

Traditional mulberry paper used to develop breathable health patch

Natural body gas could help treat severe skin and wound infections

1nhaler secures £2.2 million to continue late-stage development

Novel transporter protein discovery opens new pathways for central nervous system therapies

Implantable drug-delivery device could help prevent recurrence of glioblastoma

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

Targeting mitochondrial vulnerabilities could help treat triple-negative breast cancer

A New Approach to Preventing Bladder Cancer Recurrence

Innovative material uses visible light to disinfect chronic wounds

Terumo announces global commercial launch of K-Pack Embrace™ active safety needle

OnDosis and Adare Pharma Solutions announce strategic collaboration to advance OnDosis's lead U.S. ADHD program

New mathematical model tracks how tumor environment impacts cancer therapies

Review highlights emerging treatments for glioblastoma multiforme

Forge Nano and Nanexa enter joint development agreement to advance manufacturing for ALD-coated PharmaShell® long-acting injectable medicines

New slow-release drug delivery system provides weeks of pain-numbing anesthetic effects

Event guide: World ADC San Diego eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery